F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment. Leukemia, Whitehead, Emma, Immunotherapy, Drugs (Pharmaceuticals), Food and Drug Administration, Novartis AG, Immune System, Children and Childhood, Genetic Engineering